Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polymorphisms of Helicobacter pylori signaling pathway genes and gastric cancer risk in the European Prospective Investigation into Cancer-Eurgast cohort.
Companioni O, Bonet C, Muñoz X, Weiderpass E, Panico S, Tumino R, Palli D, Agnoli C, Vineis P, Boutron-Ruault MC, Racine A, Clavel-Chapelon F, Travis RC, Khaw KT, Riboli E, Murphy N, Vergnaud AC, Trichopoulou A, Benetou V, Trichopoulos D, Lund E, Johansen D, Lindkvist B, Johansson M, Sund M, Ardanaz E, Sánchez-Cantalejo E, Huerta JM, Dorronsoro M, Ramón Quirós J, Tjonneland A, Mortensen LM, Overvad K, Chang-Claude J, Rizzato C, Boeing H, Bueno-de-Mesquita HB, Siersema P, Peeters PH, Numans ME, Carneiro F, Licaj I, Freisling H, Sala N, González CA. Companioni O, et al. Int J Cancer. 2014 Jan 1;134(1):92-101. doi: 10.1002/ijc.28357. Epub 2013 Aug 13. Int J Cancer. 2014. PMID: 23824692 Free article.
Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14.
Companioni O, Bonet C, García N, Ramírez-Lázaro MJ, Lario S, Mendoza J, Adrados MM, Poves E, Espinosa L, Pozo-Kreilinger JJ, Ortega L, Bujanda L, Cosme A, Ferrández A, Muñoz G, Cuatrecasas M, Elizalde I, Andreu V, Paules MJ, Madrigal B, Barrio J, Berdasco M, Calvet X, Sanz-Anquela JM, Gisbert JP, González CA, Sala N; Study Group. Companioni O, et al. Int J Cancer. 2018 Dec 1;143(11):2777-2786. doi: 10.1002/ijc.31839. Epub 2018 Oct 4. Int J Cancer. 2018. PMID: 30171605 Free article.
Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer.
Companioni O, Sanz-Anquela JM, Pardo ML, Puigdecanet E, Nonell L, García N, Parra Blanco V, López C, Andreu V, Cuatrecasas M, Garmendia M, Gisbert JP, Gonzalez CA, Sala N. Companioni O, et al. PLoS One. 2017 Apr 25;12(4):e0176043. doi: 10.1371/journal.pone.0176043. eCollection 2017. PLoS One. 2017. PMID: 28441455 Free PMC article.
Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study.
González CA, Sanz-Anquela JM, Companioni O, Bonet C, Berdasco M, López C, Mendoza J, Martín-Arranz MD, Rey E, Poves E, Espinosa L, Barrio J, Torres MÁ, Cuatrecasas M, Elizalde I, Bujanda L, Garmendia M, Ferrández Á, Muñoz G, Andreu V, Paules MJ, Lario S, Ramírez MJ; Study group; Gisbert JP. González CA, et al. Among authors: companioni o. J Gastroenterol Hepatol. 2016 May;31(5):953-8. doi: 10.1111/jgh.13249. J Gastroenterol Hepatol. 2016. PMID: 26630310
Follow-Up Study Confirms the Presence of Gastric Cancer DNA Methylation Hallmarks in High-Risk Precursor Lesions.
Gómez A, Pato ML, Bujanda L, Sala N, Companioni O, Cosme Á, Tufano M, Hanly DJ, García N, Sanz-Anquela JM, Gisbert JP, López C, Elizalde JI, Cuatrecasas M, Andreu V, Paules MJ, Martín-Arranz MD, Ortega L, Poves E, Barrio J, Torres MÁ, Muñoz G, Ferrández Á, Ramírez-Lázaro MJ, Lario S, González CA, Esteller M, Berdasco M. Gómez A, et al. Among authors: companioni o. Cancers (Basel). 2021 Jun 2;13(11):2760. doi: 10.3390/cancers13112760. Cancers (Basel). 2021. PMID: 34199386 Free PMC article.
A synergistic association of ACE I/D and eNOS G894T gene variants with the progression of immunoglobulin A nephropathy - a pilot study.
Rodríguez-Pérez JC, Macías-Reyes A, Jiménez-Sosa A, Companioni O, Rodríguez-Esparragón FJ, Cobo MA, Checa-Andrés MD, Palop-Cubillo L, Alonso A, Torres A. Rodríguez-Pérez JC, et al. Among authors: companioni o. Am J Nephrol. 2009;30(3):303-9. doi: 10.1159/000225938. Epub 2009 Jun 18. Am J Nephrol. 2009. PMID: 19546528
Anti-albuminuric effects of the angiotensin AT1 receptor blocker telmisartan in hypertensive patients.
Rodríguez-Pérez JC, García-Bello MA, Anabitarte-Prieto A, Companioni O, Nóvoa-Mogollón FJ, Suárez-Ortega S, Plaza-Toledano C, Rodríguez-Esparragón F. Rodríguez-Pérez JC, et al. Among authors: companioni o. Clin Exp Hypertens. 2011;33(8):506-10. doi: 10.3109/10641963.2011.561900. Epub 2011 Sep 29. Clin Exp Hypertens. 2011. PMID: 21958392 Clinical Trial.
Targeting Sphingolipids for Cancer Therapy.
Companioni O, Mir C, Garcia-Mayea Y, LLeonart ME. Companioni O, et al. Front Oncol. 2021 Oct 19;11:745092. doi: 10.3389/fonc.2021.745092. eCollection 2021. Front Oncol. 2021. PMID: 34737957 Free PMC article. Review.
14 results